Barinthus Biotherapeutics plc. (BRNS) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $14.97M | +1766.5% |
| 2023 | $802.0K | -98.2% |
| 2022 | $44.70M | +16580.2% |
| 2021 | $268.0K | -94.4% |
| 2020 | $4.82M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $14.97M | +1766.5% |
| 2023 | $802.0K | -98.2% |
| 2022 | $44.70M | +16580.2% |
| 2021 | $268.0K | -94.4% |
| 2020 | $4.82M | — |